Venture capital investors have become significantly more cautious about investing in sectors plagued by fraud. That shows PhD research by Yanying Lyu at Tilburg University.
The conviction of Elizabeth Holmes, founder of health technology company Theranos, has shone a spotlight on the issue of Silicon Valley startup scams. Theranos, which at its peak had an estimated value of as much as $9 billion, deceived investors with false promises, allowing the startup to rake in huge sums of money.
Source: www.emerce.nl
